BR0014183A - Pharmaceutical compositions and methods of using secreted frizzled related protein - Google Patents
Pharmaceutical compositions and methods of using secreted frizzled related proteinInfo
- Publication number
- BR0014183A BR0014183A BR0014183-6A BR0014183A BR0014183A BR 0014183 A BR0014183 A BR 0014183A BR 0014183 A BR0014183 A BR 0014183A BR 0014183 A BR0014183 A BR 0014183A
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- pharmaceutical compositions
- secreted
- related protein
- sfrps
- Prior art date
Links
- 108010020277 WD repeat containing planar cell polarity effector Proteins 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 102100030053 Secreted frizzled-related protein 3 Human genes 0.000 title abstract 2
- 210000000963 osteoblast Anatomy 0.000 abstract 2
- 208000005623 Carcinogenesis Diseases 0.000 abstract 1
- 101000864743 Homo sapiens Secreted frizzled-related protein 1 Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 102100030058 Secreted frizzled-related protein 1 Human genes 0.000 abstract 1
- 230000031018 biological processes and functions Effects 0.000 abstract 1
- 230000036952 cancer formation Effects 0.000 abstract 1
- 231100000504 carcinogenesis Toxicity 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000013020 embryo development Effects 0.000 abstract 1
- 239000003102 growth factor Substances 0.000 abstract 1
- 210000004409 osteocyte Anatomy 0.000 abstract 1
- 230000002188 osteogenic effect Effects 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000026011 regulation of ossification Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Environmental Sciences (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Patente de Invenção: "COMPOSIçõES FARMACEUTICAS E MéTODOS DE USO DE PROTEìNA RELACIONADA FRIZZLED SECRETADA". São apresentadas composições farmacêuticas e métodos de uso na regulação de atividades de formação óssea em mamíferos, da SFRPs (proteínas relacionadas frizzied secretadas). As SFRPs são receptores secretados para Wnts, que são fatores de crescimento polipeptídicos importantes, que, como se conhece, regulam os processos biológicos fundamentais como polaridade tecidual, desenvolvimento embriónico e tumorigênese. Uma SFRP foi isolada em células de osteoblastos humanos e identificadas como SFRP-1 (também conhecida como SARP-2) e apresentada como sendo regulada por agentes osteogênicos nas células hOB de uma maneira seletiva de diferenciação modulando a vida de osteoblastos/pré-osteócitos.Invention Patent: "PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF SECRETED FRIZZLED RELATED PROTEIN". Pharmaceutical compositions and methods of use in the regulation of bone formation activities in mammals, of SFRPs (related frizzied secreted proteins) are presented. SFRPs are secreted receptors for Wnts, which are important polypeptide growth factors, which, as is known, regulate fundamental biological processes such as tissue polarity, embryonic development and tumorigenesis. An SFRP was isolated in human osteoblast cells and identified as SFRP-1 (also known as SARP-2) and presented as being regulated by osteogenic agents in hOB cells in a selective way of differentiating by modulating the life of osteoblasts / pre-osteocytes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39483299A | 1999-09-13 | 1999-09-13 | |
PCT/US2000/025035 WO2001019855A2 (en) | 1999-09-13 | 2000-09-13 | Pharmaceutical compositions and methods of using secreted frizzled related protein |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0014183A true BR0014183A (en) | 2002-05-14 |
Family
ID=23560597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0014183-6A BR0014183A (en) | 1999-09-13 | 2000-09-13 | Pharmaceutical compositions and methods of using secreted frizzled related protein |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1212355A2 (en) |
JP (1) | JP2003512304A (en) |
CN (2) | CN102988957A (en) |
AU (1) | AU7131200A (en) |
BR (1) | BR0014183A (en) |
CA (1) | CA2383360A1 (en) |
CZ (1) | CZ2002903A3 (en) |
IL (1) | IL148421A0 (en) |
MX (1) | MXPA02002624A (en) |
NZ (1) | NZ529560A (en) |
WO (1) | WO2001019855A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1974738A3 (en) | 2000-02-29 | 2008-12-17 | Alcon, Inc. | Diagnostics and therapeutics for glaucoma |
US6600018B1 (en) | 2000-04-10 | 2003-07-29 | The United States Of America As Represented By The Department Of Health And Human Services | Secreted frizzled related protein, sFRP, fragments and methods of use thereof |
US20020115627A1 (en) * | 2000-07-19 | 2002-08-22 | Susan Schiavi | Phosphatonin-related gene and methods of use thereof |
CA2434672C (en) | 2001-01-10 | 2014-03-25 | Jeffrey S. Rubin | Sfrp and peptide motifs that interact with sfrp and methods of their use |
EP1222933A1 (en) * | 2001-01-15 | 2002-07-17 | Academisch Ziekenhuis Leiden h.o.d.n., Leids Universitair Medisch Centrum | Generation and/or reduction of new lung tissue in an affected lung, by modulation of the Wnt-pathway |
US20040265808A1 (en) * | 2001-04-05 | 2004-12-30 | Teresa Garcia | Genes involved in osteogenesis, and methods of use |
US7713526B2 (en) | 2001-05-01 | 2010-05-11 | The Regents Of The University Of California | Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas |
AU2002308557A1 (en) | 2001-05-01 | 2002-11-11 | The Regents Of The University Of California | Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas |
GB0111004D0 (en) * | 2001-05-04 | 2001-06-27 | Univ Sheffield | Screening method |
WO2003042384A1 (en) * | 2001-11-15 | 2003-05-22 | Kyowa Hakko Kogyo Co., Ltd. | Inducer for differentiation of embryo stem cells into ectodermal cells, method of obtaining the same and use thereof |
WO2004053063A2 (en) * | 2002-12-05 | 2004-06-24 | The Board Of Trustees Of The University Of Arkansas System | Molecular determinants of myeloma bone disease and uses thereof |
EP2065395A1 (en) * | 2003-04-14 | 2009-06-03 | Novartis AG | Gene expression associated with osteoblast differentiation |
CN104726460A (en) * | 2013-12-22 | 2015-06-24 | 上海交通大学医学院 | Application of protein SFRP-5 in drug for treating psoriasis |
KR101835939B1 (en) * | 2014-08-26 | 2018-03-23 | 연세대학교 산학협력단 | An antibody that recognizes a specific motif of WLS protein and a pharmaceutical composition comprising the same |
EP3696192A1 (en) * | 2019-02-15 | 2020-08-19 | Consejo Superior De Investigaciones Científicas | Therapeutic target and monoclonal antibodies against it for the diagnosis and treatment of alzheimer´s disease |
CN110361541A (en) * | 2019-07-23 | 2019-10-22 | 上海交通大学医学院附属瑞金医院 | SFRP2 and PCPE1 is preparing the application in fibrotic disease drug as joint target spot |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5681701A (en) * | 1993-07-12 | 1997-10-28 | Mayo Foundation For Medical Education And Research | Immortalized human fetal osteoblastic cells |
CA2191980A1 (en) * | 1994-07-04 | 1996-01-18 | Takashi Sohda | Phosphonic acid compounds, their production and use |
WO1998016641A1 (en) * | 1996-10-11 | 1998-04-23 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Isolation and method of using tissue growth-inducing frzb protein |
AU7704498A (en) * | 1997-05-29 | 1998-12-30 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Human frp and fragments thereof including methods for using them |
-
2000
- 2000-09-13 IL IL14842100A patent/IL148421A0/en unknown
- 2000-09-13 AU AU71312/00A patent/AU7131200A/en not_active Abandoned
- 2000-09-13 CN CN200910208473XA patent/CN102988957A/en active Pending
- 2000-09-13 JP JP2001523632A patent/JP2003512304A/en active Pending
- 2000-09-13 WO PCT/US2000/025035 patent/WO2001019855A2/en active Application Filing
- 2000-09-13 NZ NZ529560A patent/NZ529560A/en not_active IP Right Cessation
- 2000-09-13 BR BR0014183-6A patent/BR0014183A/en not_active IP Right Cessation
- 2000-09-13 MX MXPA02002624A patent/MXPA02002624A/en active IP Right Grant
- 2000-09-13 CN CN00815431A patent/CN1387537A/en active Pending
- 2000-09-13 CZ CZ2002903A patent/CZ2002903A3/en unknown
- 2000-09-13 CA CA002383360A patent/CA2383360A1/en not_active Abandoned
- 2000-09-13 EP EP00960097A patent/EP1212355A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CN102988957A (en) | 2013-03-27 |
AU7131200A (en) | 2001-04-17 |
CN1387537A (en) | 2002-12-25 |
CA2383360A1 (en) | 2001-03-22 |
MXPA02002624A (en) | 2002-07-30 |
WO2001019855A2 (en) | 2001-03-22 |
EP1212355A2 (en) | 2002-06-12 |
IL148421A0 (en) | 2002-09-12 |
WO2001019855A3 (en) | 2002-01-24 |
JP2003512304A (en) | 2003-04-02 |
CZ2002903A3 (en) | 2002-07-17 |
NZ529560A (en) | 2005-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0014183A (en) | Pharmaceutical compositions and methods of using secreted frizzled related protein | |
Canalis | Effect of hormones and growth factors on alkaline phosphatase activity and collagen synthesis in cultured rat calvariae | |
CY1119263T1 (en) | COMPOSITIONS AND METHODS FOR BONE BALANCING INCREASE | |
DE69839815D1 (en) | USE OF PPAR-GAMMA ACTIVATORS FOR THE TREATMENT OF SKIN DISEASES | |
EA200000298A1 (en) | Prostaglandin agonists and their application for the treatment of bone diseases | |
DE69841850D1 (en) | DIFFERENTIATION IN OSTEOBLASTS OF FAT-TISSUE-STROMAL CELLS AND ITS USES | |
Lee et al. | Synergistic effect of growth factors on cell outgrowth from explants of rabbit anterior cruciate and medial collateral ligaments | |
DE69630389D1 (en) | BIOACTIVE COMPOSITE MATERIAL FOR REPAIRING HARD AND SOFT TISSUE | |
ES2146552B1 (en) | INHIBITING PEPTIDES OF TGF / 31 | |
BR0214021A (en) | Adipose-derived stromal cells, compositions and methods for the use of such cells in the treatment and repair of any defect associated with ocular tissue. | |
ATE382053T1 (en) | SYSTEM FOR ANTIBODIES EXPRESSION AND SYNTHESIS | |
BRPI0411112A (en) | heterologous fusion protein, polynucleotide, vector, host cell, process for producing a heterologous fusion protein, method for treating a patient, and use of heterologous fusion protein | |
ATE114169T1 (en) | MORPHOGENETIC BONE PROTEIN. | |
AR014261A1 (en) | BENZOTIAZEPINE HYPOLIPIDEMIC COMPOUNDS, COMPOSITIONS AND PROCESS FOR PREPARATION | |
BR0214029A (en) | Methods and compositions for using stromal cells to support embryonic and adult stem cells | |
DE69724777D1 (en) | PENTAFLUOROBENZEN SULPHONAMIDES AND ANALOGS | |
ATE423577T1 (en) | BIOLOGICALLY MODELED IMPLANTABLE PROSTHESES | |
IT1260148B (en) | USE OF HYALURONIC ACID PREPARATIONS FOR THE FORMATION OF BONE TISSUE | |
ATE515268T1 (en) | USE OF OP-1 TO TREAT CARTILAGE DEFECTS | |
ATE262519T1 (en) | HETEROCYCLIC ETHER AND THIOETHER COMPOUNDS USABLE FOR CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION | |
ATE404668T1 (en) | GROWTH FACTOR HOMOLOGUE ZVEGF-3 | |
ATE258791T1 (en) | LIPOXIN-A4 AND THEIR ANALOGUES FOR THE TREATMENT OF DRY EYES | |
DE69726884D1 (en) | HUMAN SDF-5 PROTEIN AND RELATED COMPOSITIONS | |
ES2382464T3 (en) | Mutants of high activity growth factor | |
PT811001E (en) | BENZOTIAZINE DIOXIDES AS ENDOTHELINE ANTAGONISTS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 12A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2166 DE 10/07/2012. |